POLR2A and benign meningioma: Clark et al. later discovered a specific subset of benign meningiomas characterized by recurrent mutations in POLR2A, confirmed as somatic in all tumor tissue specimens with available blood pairing, for the first time describing an implication of POLR2A in human disease.